Literature DB >> 12454858

Diverse expression of ErbB receptor proteins during rat liver development and regeneration.

Robert S Carver1, Mary C Stevenson, Lawrence A Scheving, William E Russell.   

Abstract

BACKGROUND & AIMS: The protein expression and interactions of the ErbB receptors were examined in different liver proliferation models in vivo and in vitro, including ontogeny and regeneration following partial hepatectomy.
METHODS: Expression and tyrosine phosphorylation status of specific ErbB proteins were studied by immunologic methods.
RESULTS: The epidermal growth factor receptor, ErbB2, and ErbB3 were the only ErbB proteins detected in the liver parenchyma on embryonic day 19. ErbB2 disappeared by the third week after birth and could not be appreciably induced in the adult animal by partial hepatectomy. ErbB2 was also detected in multipotent stem (RLE) and hepatoma (H4IIe) cell lines as well as in fetal, but not adult, hepatocyte cultures. Only epidermal growth factor receptor and ErbB3 were detected in adult liver, and both showed circadian variation in protein expression. ErbB4 was not detected in any model. Patterns of ligand-induced ErbB phosphorylation differed between fetal and adult hepatocytes.
CONCLUSIONS: Complex and independent programs regulate the ErbB receptors, with implications for differential cell signaling in hepatic development and regeneration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12454858     DOI: 10.1053/gast.2002.37060

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  34 in total

1.  Designed hydrophilic and charge mutations of the fibronectin domain: towards tailored protein biodistribution.

Authors:  Benjamin J Hackel; Ataya Sathirachinda; Sanjiv S Gambhir
Journal:  Protein Eng Des Sel       Date:  2012-06-12       Impact factor: 1.650

2.  Combined systemic elimination of MET and epidermal growth factor receptor signaling completely abolishes liver regeneration and leads to liver decompensation.

Authors:  Shirish Paranjpe; William C Bowen; Wendy M Mars; Anne Orr; Meagan M Haynes; Marie C DeFrances; Silvia Liu; George C Tseng; Anastasia Tsagianni; George K Michalopoulos
Journal:  Hepatology       Date:  2016-10-01       Impact factor: 17.425

3.  Liver regeneration, growth factors, and amphiregulin.

Authors:  George K Michalopoulos; Zahida Khan
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

Review 4.  Calcium signaling in the liver.

Authors:  Maria Jimena Amaya; Michael H Nathanson
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

5.  Epidermal growth factor receptor plays a role in the regulation of liver and plasma lipid levels in adult male mice.

Authors:  Lawrence A Scheving; Xiuqi Zhang; Oscar A Garcia; Rebecca F Wang; Mary C Stevenson; David W Threadgill; William E Russell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-01-09       Impact factor: 4.052

6.  Combined Systemic Disruption of MET and Epidermal Growth Factor Receptor Signaling Causes Liver Failure in Normal Mice.

Authors:  Anastasia Tsagianni; Wendy M Mars; Bharat Bhushan; William C Bowen; Anne Orr; John Stoops; Shirish Paranjpe; George C Tseng; Silvia Liu; George K Michalopoulos
Journal:  Am J Pathol       Date:  2018-07-20       Impact factor: 4.307

7.  Loss of hepatocyte ERBB3 but not EGFR impairs hepatocarcinogenesis.

Authors:  Lawrence A Scheving; Xiuqi Zhang; Mary C Stevenson; Michael A Weintraub; Annam Abbasi; Andrea M Clarke; David W Threadgill; William E Russell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-10-22       Impact factor: 4.052

8.  The microRNA-30 family is required for vertebrate hepatobiliary development.

Authors:  Nicholas J Hand; Zankhana R Master; Steven F Eauclaire; Daniel E Weinblatt; Randolph P Matthews; Joshua R Friedman
Journal:  Gastroenterology       Date:  2008-12-09       Impact factor: 22.682

9.  The logic of EGFR/ErbB signaling: theoretical properties and analysis of high-throughput data.

Authors:  Regina Samaga; Julio Saez-Rodriguez; Leonidas G Alexopoulos; Peter K Sorger; Steffen Klamt
Journal:  PLoS Comput Biol       Date:  2009-08-07       Impact factor: 4.475

10.  Increased expression of ErbB-2 in liver is associated with hepatitis B x antigen and shorter survival in patients with liver cancer.

Authors:  Jie Liu; Angela Ahiekpor; Li Li; Xianxing Li; Patrick Arbuthnot; Michael Kew; Mark A Feitelson
Journal:  Int J Cancer       Date:  2009-10-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.